Aurora Cannabis Inc. (ACB) Earnings Call Analysis

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings Reports

• Aurora Cannabis (ACB) Q3 2026: Medical Cannabis Hits 81% of Revenue as Global Focus Deepens
  June 15, 2026
• Aurora Cannabis (ACB) Q4 2026: International Medical Cannabis Surges to 58% of Revenue as Canada Reimbursement Cuts Bite
  June 11, 2026
• Aurora Cannabis (ACB) Q2 2026: Medical Margins Hit 69% as International Revenue Climbs 22%
  November 05, 2025
• Aurora Cannabis (ACB) Q1 2026: Global Medical Revenue Soars 85% as International Expansion Drives Margin Upside
  August 06, 2025
• ACB Q4 2025: Medical Cannabis Revenue Jumps 48% as International Margins Expand
  July 02, 2025
• Aurora Cannabis (ACB) Q2 2025: International Medical Cannabis Revenue Jumps 93% as Global Shift Accelerates
  November 06, 2024
• Aurora Cannabis (ACB) Q1 2025: Medical Cannabis Margins Hit 69% as Global Expansion Accelerates
  August 07, 2024
• Aurora Cannabis (ACB) Q4 2024: Medical Cannabis Margins Hit 66% as Global Expansion Accelerates
  June 20, 2024
• Aurora Cannabis (ACB) Q3 2024: International Medical Revenue Jumps 41% as Australia Acquisition Reshapes Global Footprint
  February 08, 2024
• Aurora Cannabis (ACB) Q2 2024: Medical Revenue Jumps 42% as International Expansion Drives Margin Strength
  November 09, 2023

Browse all companies